RC

Reference Capital

North America, Oregon, United States, Portland

Description

Reference Capital focuses its investment management on market sectors and opportunities.

Investor Profile

Reference Capital has made 11 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (27%)
  • Series A (18%)
  • Series G (9%)
  • Series F (9%)
  • Seed (9%)
  • Series C (9%)
  • Convertible Note (9%)
  • Series B (9%)

Country Focus

  • United States (82%)
  • Norway (18%)

Industry Focus

  • Biotechnology
  • Energy
  • Internet
  • Real Time
  • Software
  • Recycling
  • Renewable Energy
  • Sustainability
  • Chemical
  • Cleantech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Reference Capital frequently co-invest with?

TotalEnergies Ventures
Europe, Ile-de-France, France, La Défense
Co-Investments: 2
OL
North America, Oregon, United States, Eugene
Co-Investments: 2
Next47
North America, California, United States, Palo Alto
Co-Investments: 2
Ventures West
North America, British Columbia, Canada, Vancouver
Co-Investments: 3
Perseus
North America, District of Columbia, United States, Washington
Co-Investments: 2
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 2
Chrysalix Venture Capital
North America, British Columbia, Canada, Vancouver
Co-Investments: 2
ED
North America, Arizona, United States, Phoenix
Co-Investments: 2
Nth Power
North America, California, United States, San Francisco
Co-Investments: 2
Saffron Hill Ventures
Europe, England, United Kingdom, London
Co-Investments: 2

Which angels does Reference Capital often collaborate with?

AA
North America, Oregon, United States, Lake Oswego
Shared Deals: 1

What are some of recent deals done by Reference Capital?

Spark Grills

Boulder, Colorado, United States

Spark Grills features proprietary wood and charcoal Briq system, loading and quick ignition in simple, seamless, and mess-free.

CateringConsumer GoodsCooking
SeedMay 7, 2021
Virogenomics BioDevelopment

Portland, Oregon, United States

Virogenomics BioDevelopment recognize the challenge of advancing early stage technology out of the lab and into the marketplace.

BiotechnologyMarketplace
Series UnknownJan 1, 2018
Diatomix

Beaverton, Oregon, United States

Diatomix is an air-purifying technology company that offers an all-inclusive OEM air-purifying additive.

ChemicalCleanTechNanotechnology
Series UnknownJan 1, 2018
TwinStrand Biosciences

Seattle, Washington, United States

TwinStrand Biosciences develops and commercializes the duplex sequencing technology for DNA sequencing.

BiotechnologyGeneticsHealth Care
Series UnknownSep 13, 2017
Amount Raised: $5,280,338
Indice Semiconductor

Tualatin, Oregon, United States

Indice Semiconductor develops integrated circuit chips designed to offer innovative power control technology.

AudioEnterprise ApplicationsSemiconductor
Series ANov 12, 2014
Amount Raised: $6,000,000
Agilyx

Oslo, Oslo, Norway

Agilyx is a pioneer in chemically recycling difficult-to-recycle post.

RecyclingRenewable EnergySustainability
Series CDec 19, 2011
Amount Raised: $25,000,000
Agilyx

Oslo, Oslo, Norway

Agilyx is a pioneer in chemically recycling difficult-to-recycle post.

RecyclingRenewable EnergySustainability
Series BMar 31, 2011
Amount Raised: $22,000,000
RNA Networks

Portland, Oregon, United States

RNA Networks offers a memory virtualization platform that makes memory a shared resource and accelerates the speed of a business.

Enterprise SoftwareInformation TechnologyVirtualization
Series AFeb 3, 2009
Amount Raised: $7,000,000
Serveron

Hillsboro, Oregon, United States

Serveron Corporation develops, delivers, and supports online transformer products and diagnostic services.

EnergyInternetReal TimeSoftware
Series GMar 22, 2007
Amount Raised: $5,000,000
Osprey Pharmaceuticals USA

San Francisco, California, United States

Osprey Pharmaceuticals USA develops novel protein therapeutics for the treatment of inflammatory and immune diseases.

BiotechnologyMedicalPharmaceutical
Convertible NoteJan 30, 2007
Amount Raised: $6,000,000